Nrx pharmaceuticals, inc.NRXPW.US Overview
US StockHealthcare
(No presentation for NRXPW)
NRXPW Overall Performance
NRXPW AI Analysis & Strategy
NRXPW Recent Performance
-
Nrx pharmaceuticals, inc.
0.81%
Avg of Sector
-1.14%
S&P500
NRXPW PowerScanner
NRXPW Key Information
NRXPW Valuation Metrics
NRXPW Earnings Table
NRXPW Profile
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.